Mark Kimmins - Sunniva Pres NHS
Insider
Mark Kimmins is Pres NHS of Sunniva
| Age | 56 |
| Phone | 866 786 6482 |
| Web | https://www.sunniva.com |
Sunniva Management Efficiency
The company has return on total asset (ROA) of (0.1679) % which means that it has lost $0.1679 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6406) %, meaning that it generated substantial loss on money invested by shareholders. Sunniva's management efficiency ratios could be used to measure how well Sunniva manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jonathan JD | AYR Strategies Class | 65 | |
| Advocate Ohayon | INC Research Holdings | 35 | |
| Jessie Casner | Flora Growth Corp | 36 | |
| Albert Zakes | Goodness Growth Holdings | N/A | |
| Rami Levy | INC Research Holdings | 59 | |
| CPA CPA | Flora Growth Corp | N/A | |
| Joshua Rosen | Goodness Growth Holdings | 50 | |
| Jennifer Drake | AYR Strategies Class | N/A | |
| MBA MBA | Painreform | 55 | |
| John Heller | Goodness Growth Holdings | 54 | |
| Sam Gibbons | Goodness Growth Holdings | N/A | |
| FCA FCA | Flora Growth Corp | 79 | |
| Matthew Cohen | Flora Growth Corp | 58 | |
| Amber Shimpa | Goodness Growth Holdings | 44 | |
| Javier Franco | Flora Growth Corp | 56 | |
| Brad Asher | AYR Strategies Class | N/A | |
| Stephen MD | Goodness Growth Holdings | 48 | |
| Amos Cohen | INC Research Holdings | 46 | |
| Luis Merchan | Flora Growth Corp | 43 | |
| Jeff Finnerty | AYR Strategies Class | N/A | |
| James Mendola | AYR Strategies Class | N/A | |
Management Performance
| Return On Equity | -0.64 | |||
| Return On Asset | -0.17 |
Sunniva Leadership Team
Elected by the shareholders, the Sunniva's board of directors comprises two types of representatives: Sunniva inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sunniva. The board's role is to monitor Sunniva's management team and ensure that shareholders' interests are well served. Sunniva's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sunniva's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anthony MD, CEO Cofounder | ||
| Mark Kimmins, Pres NHS | ||
| David Weinmann, Global CFO | ||
| Rob Knowles, VP Devel | ||
| Jose Calderon, Head Grower |
Sunniva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sunniva a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.64 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (1.43) % | |||
| Operating Margin | (0.88) % | |||
| Current Valuation | 46.08 M | |||
| Shares Outstanding | 39.21 M | |||
| Price To Book | 0.04 X | |||
| Price To Sales | 0 X | |||
| Revenue | 18.79 M | |||
| Gross Profit | 7.8 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Sunniva Pink Sheet
Sunniva financial ratios help investors to determine whether Sunniva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sunniva with respect to the benefits of owning Sunniva security.